Dexrazoxane Intravenous and Repaglinide and Metformin
Determining the interaction of Dexrazoxane Intravenous and Repaglinide and Metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: metformin / repaglinide
Brand name: PrandiMet
Synonyms: Metformin and repaglinide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Repaglinide and Metformin Tablets
- Dexrazoxane Intravenous-Repaglinide Tablets
- Dexrazoxane Intravenous-Repan
- Dexrazoxane Intravenous-Repara Silver Nitrate Applicators
- Dexrazoxane Intravenous-Replace
- Dexrazoxane Intravenous-Replace Without Iron
- Repaglinide and Metformin-Dextenza Insert
- Repaglinide and Metformin-Dextenza intraocular
- Repaglinide and Metformin-Dextran 40
- Repaglinide and Metformin-Dextran 70 6% in 5% Dextrose high molecular weight
- Repaglinide and Metformin-Dextran 75
- Repaglinide and Metformin-Dextran high molecular weight